WADA Prohibited List comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-01-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human therapeutic use | No marketing authorization identified in major jurisdictions. |
| Anti-doping class | PPARδ agonist; hormone and metabolic modulators | Listed on the WADA Prohibited List. |
| Common test matrix | Urine | Also blood and tissue in research settings. |
| Typical analytical method | LC-MS/MS | Targets parent compound and metabolites. |
| Major safety signal | Tumor findings in rodents | Human relevance not established; limited human data. |
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
From its founding until the early 1990s, the menu at Domino's Pizza was kept simple relative to other fast food restaurants, to ensure efficiency of delivery. Historically, Domino's menu consisted solely of one style of pizza crust in two sizes (12-inch and 16-inch), eleven toppings, and Coca-Cola as the only soft drink option. The first menu expansion occurred in 1989, with the debut of Domino's deep dish. Its introduction followed market research showing that 40% of pizza customers preferred thick crusts. The new product launch cost approximately $25 million, of which $15 million was spent on new sheet metal pans with perforated bottoms. Domino's started testing extra-large-size pizzas in early 1993, starting with the 30-slice, yard-long "The Dominator". Domino's tapped into a market trend toward bite-size foods with spicy "Buffalo Chicken Kickers", as an alternative to Buffalo wings, in August 2002. The breaded, baked, white-meat fillets, similar to chicken fingers, are packaged in a custom-designed box with two types of sauce to "heat up" and "cool down" the chicken.
=== Inflammatory and immune-related diseases === Microbial therapeutics are being studied for the treatment of inflammatory and immune-related diseases, including inflammatory bowel disease (IBD), allergies, and autoimmune disorders. In these conditions, the immune system becomes overactive or poorly regulated, leading to chronic inflammation. Certain microorganisms can help reduce inflammation by promoting immune balance. For example, some gut microbes produce molecules that calm inflammatory immune responses or support immune cells that help prevent excessive inflammation. Researchers are also developing engineered microorganisms that can release anti-inflammatory substances directly at sites of inflammation, which may reduce side effects compared with treatments that affect the entire body.
In the early post approval period lurasidone-treated patients with bipolar disorder were retrospectively found to have more complex clinical profiles, comorbidities, and prior treatment history compared to patients initiated with other atypical antipsychotics. The study authors suggest this may be due to "the overall clinical profile of lurasidone, the role perceived for lurasidone in the therapeutic armamentarium by practitioners, and the recent introduction of lurasidone into clinical practice during the study period".
Sources: en.wikipedia.org
Nobel Prize in Chemistry (2004). Member Natl. Acad. Sci. USA. Barry P. Rosen (b. 1944), American biochemist at Florida International University known for pioneering research into the molecular mechanisms of arsenic and antimony transport and detoxification. Sinaida Rosenthal (1932–1988). German biochemist and molecular biologist at the Humboldt University of Berlin who studied molecular biological and genetic aspects of physiology. William J. Rutter (1927–2025). American biochemist at the Chiron Corporation who contributed to the development of biotechnology.
== Signs and symptoms == Generally, fractures are a result of traumatic injury, underlying pathology, or overuse. Fractures are painful though there are no pain receptors in the bone. This is a result of damage to the periosteum and endosteum, hematoma formation, soft tissue injury, and contraction of nearby muscle groups in response to disturbed anatomy. Physical signs include obvious deformity, inability to bear weight or use the limb, bruising, and swelling.
=== Remote influence on tropical Atlantic Ocean === A study of climate records has shown that El Niño events in the equatorial Pacific are generally associated with a warm tropical North Atlantic in the following spring and summer. About half of El Niño events persist sufficiently into the spring months for the Western Hemisphere Warm Pool to become unusually large in summer. Occasionally, El Niño's effect on the Atlantic Walker circulation over South America strengthens the easterly trade winds in the western equatorial Atlantic region. As a result, an unusual cooling may occur in the eastern equatorial Atlantic in spring and summer following El Niño peaks in winter. Cases of El Niño-type events in both oceans simultaneously have been linked to severe famines related to the extended failure of monsoon rains.
Litvinenko in 2006, and was suspected as a possible cause of Yasser Arafat's death, following exhumation and analysis of his corpse in 2012–2013. The radioisotope may also have been used to kill Yuri Shchekochikhin, Lecha Islamov and Roman Tsepov.
Sources: en.wikipedia.org
==== Marquez: The Wannabe B-Boy ==== Meet Marquez, a street fighter who makes life miserable for twins Richard and Edward. Mayhem brings in Brazilian jiu-jitsu specialist, Quinn Mulhern standing at 6'3 and weighing in at 177 lbs, with a record of 14 wins and 1 loss to put him in his place. This episode has never aired on American TV and is not available on the Bully Beatdown website like most other episodes. The episode has been aired in the Netherlands, the Fox8 channel of Foxtel and Austar in Australia, and MTV Latin America. Many have speculated that the bully winning more money is the reason why it was never broadcast in America.
=== Uniforms === Battledress - Used until the 1960s Boots, General Service Khaki drill Denison smock - Used in airborne units until the 1970s 1950 Pattern Jungle Green Dress Boots, Tropical Jungle 1960 Pattern Combat Dress - Produced in olive green and then in Disruptive Pattern Material. Boots, Directly Moulded Sole 1968 Pattern No. 8 Combat Dress - Produced in Disruptive Pattern Material. Smock Parachutist DPM Lightweight Trousers - Produced in olive green No. 9 Tropical Dress 1984 Pattern Combat Dress Boots, Combat, High
Harry Emerson. For services to the community in Stockton-on-Tees, Cleveland. Elizabeth Margaret Evans. For services to the community, particularly Disabled People, in Llanelli, Dyfed. Shirley Everett, Newsvendor. For services to the community in Westminster, London. Doris Mabel Eves. For services to the Citizens' Advice Bureau in Farnborough, Hampshire. George Fitton Exley, Honorary Secretary, Scarborough Lifeboat Station. For services to the Royal National Lifeboat Institution. Ellen Branker Farmer, President, Old Paisley Society. For services to Conservation. Margaret Winifred Farmer. For services to the Royal British Legion in Sevenoaks, Kent. Eric Arnold Faux. For services to disabled people in Birmingham Valerie Ann Fea, lately Executive Secretary, the School Library Association. For services to Librananship and to Young People. Heather Duncan Findlay, Local Officer 2, the Benefits Agency, Department of Social Security. Nina Mary Fineron, lately Typist, Department of Social Security. Isabel H. Finlay, lately Chiropodist, Glasgow. For services to Health Care. Millar Henry Finlay, Divisional Officer, (Special Constabulary), Flintshire Division, North Wales Police. For services to the Police. Olwen Finlay. For services to Physiotherapy. Evelyn May Fisher. For services to Netball in Coventry. Myra Caroline Fisher. For services to the community in Paulsgrove, Portsmouth, Hampshire. Bernard Joseph Fitzsimmons. For public service. Michael Robert Flegg, Catering Manager, Nottingham City Hospital. For services to Health Care. Iris Mary Fletcher.
Sources: en.wikipedia.org
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.
It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.
Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.